Abstract
Members of the viral family Flaviviridae are a major cause of infectious diseases, such as hepatitis C, Dengue fever, Japanese encephalitis, Yellow fever or West Nile fever. Major efforts are therefore being made to identify medicines that can fight these infections. The genome of the Flaviviridae contains a single ORF that is translated into a precursor polyprotein which is processed in the host into several proteins. Amongst these, the nonstructural protein 3 (NS3) is formed from two domains that show distinct catalytic activities: a serine protease and a helicase activity. Since both activities are required for viral replication, there is a lot of interest in investigating NS3 as a potential drug target. On the basis of the structural information available, we shall assess here the druggability of the helicase domain of NS3.
Keywords: NS3 helicase, hepatitis C virus, dengue virus, west nile virus
Current Chemical Biology
Title: NS3 Helicases as Drug Targets
Volume: 3 Issue: 3
Author(s): Patrick Chene
Affiliation:
Keywords: NS3 helicase, hepatitis C virus, dengue virus, west nile virus
Abstract: Members of the viral family Flaviviridae are a major cause of infectious diseases, such as hepatitis C, Dengue fever, Japanese encephalitis, Yellow fever or West Nile fever. Major efforts are therefore being made to identify medicines that can fight these infections. The genome of the Flaviviridae contains a single ORF that is translated into a precursor polyprotein which is processed in the host into several proteins. Amongst these, the nonstructural protein 3 (NS3) is formed from two domains that show distinct catalytic activities: a serine protease and a helicase activity. Since both activities are required for viral replication, there is a lot of interest in investigating NS3 as a potential drug target. On the basis of the structural information available, we shall assess here the druggability of the helicase domain of NS3.
Export Options
About this article
Cite this article as:
Chene Patrick, NS3 Helicases as Drug Targets, Current Chemical Biology 2009; 3 (3) . https://dx.doi.org/10.2174/2212796810903030334
DOI https://dx.doi.org/10.2174/2212796810903030334 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Current Pharmaceutical Design QSAR Studies on HSV-1 Inhibitors by CoMFA, CoMSIA and HQSAR Approaches
Letters in Drug Design & Discovery Encapsulation – a Convenient Way to Extend the Persistence of the Effect of Eco-Friendly Mosquito Larvicides
Current Organic Chemistry Discovery, SAR and Medicinal Chemistry of Herpesvirus Helicase Primase Inhibitors
Current Medicinal Chemistry - Anti-Infective Agents Emerging Evidence for Neuropsycho-Consequences of COVID-19
Current Neuropharmacology Novel Antiviral Strategies to Combat Human Arenavirus Infections
Current Molecular Medicine Antiviral Agents in the Prevention and Treatment of Virus-Induced Diabetes
Anti-Infective Agents in Medicinal Chemistry Possible Roles of Microglial Cells for Neurotoxicity in Clinical Neurodegenerative Diseases and Experimental Animal Models
Inflammation & Allergy - Drug Targets (Discontinued) Immunobiology of Herpes Simplex Virus and Cytomegalovirus Infections of the Fetus and Newborn
Current Immunology Reviews (Discontinued) Intracellular Protozoan Parasites of Humans: The Role of Molecular Chaperones in Development and Pathogenesis
Protein & Peptide Letters Lipid-Activated Nuclear Receptors and Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Epigenetic Drugs for Multiple Sclerosis
Current Neuropharmacology The Potential for Genetically Altered Microglia to Influence Glioma Treatment
CNS & Neurological Disorders - Drug Targets Biosynthesis and Biological Activities of In Vitro Derived Solasodine Glycoalkaloids from <i>Solanum laciniatum</i>
The Natural Products Journal Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Visualising Neuroinflammation in Post-Stroke Patients: A Comparative PET Study with the TSPO Molecular Imaging Biomarkers [<sup>11</sup>C]PK11195 and [<sup>11</sup>C]vinpocetine
Current Radiopharmaceuticals The Critical Role of Toll-Like Receptor Signaling Pathways in the Induction and Progression of Autoimmune Diseases
Current Molecular Medicine PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders
Current Pharmaceutical Design Curcumin: Structure-Activity Relationship Towards its Role as a Versatile Multi-Targeted Therapeutics
Mini-Reviews in Organic Chemistry New Drug Targets for Hepatitis C and Other Flaviviridae Viruses
Infectious Disorders - Drug Targets